The BRAS DDP

Hospitals & Physicians Clinics · Canada · 11-50 Employees

View Company Info for Free

Overview

Headquarters

610 University Ave, Toronto, Ontario, M5...

Phone Number

(416) 946-6560

Revenue

<$5 Million

Industry

Hospitals & Physicians Clinics Business Services Research & Development Medical & Surgical Hospitals
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About The BRAS DDP

The BRAS Drug Development Program (BRAS DDP) is a leading cancer research initiative based at the Princess Margaret Cancer Centre in Toronto, recognized as the largest program in Canada and among the top five globally. Established to provide personalized cancer care, it focuses on conducting early phase clinical trials for patients with advanced cancers, utilizing innovative drug studies to enhance treatment outcomes. With over $60.6 million in peer-reviewed funding since 2001, it is the only non-U.S. program funded by the U.S. National Institute of Health. The program aims to address the growing cancer crisis in Canada, where a significant portion of the population is affected by the disease.Explore more
Popular SearchesThe BRAS DDPBRAS Drug Development ProgramBras DdpDrug Development ProgramSIC Code 80,806NAICS Code 62,622Show more

Is The BRAS DDP your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to The BRAS DDP

Compare insights from companies similar to The BRAS DDP, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

The BRAS DDP

<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
AG
Ashley Goldhawk-WhiteCustomer Service Representative
<$5M
11-50
Private
-
2009
KC
Keilani CarrollDirector, Finance & Administration
<$5M
11-50
Private
-
1995
Deborah Lehmann, President & Chief Executive Officer at Ottawa Regional Cancer Foundation
Deborah LehmannPresident & CEO
<$5M
11-50
Private
-
2008
N/A
<$5M
11-50
Private
-
2004
N/A
<$5M
1-10
Private
-
1996
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Hospitals & Physicians Clinics companies

Low Activity

High Activity

Activity Insights

The BRAS DDP is experiencing very low activity levels compared to other companies in the Hospitals & Physicians Clinics sector.

What does this means?

The BRAS DDP is drawing exceptional interest within the Hospitals & Physicians Clinics industry, suggesting notable developments or strong market momentum, learn more about The BRAS DDP.

The BRAS DDP Tech Stack

A closer look at the technologies used by The BRAS DDP

Top Hospitals & Physicians Clinics Companies

Frequently Asked Questions Regarding The BRAS DDP

What is The BRAS DDP's official website?
The BRAS DDP's official website is www.brasddp.com
What is The BRAS DDP's Revenue?
The BRAS DDP's revenue is <$5 Million
What is The BRAS DDP's SIC code?
The BRAS DDP's SIC: 80,806
What is The BRAS DDP's NAICS code?
The BRAS DDP's NAICS: 62,622
How many employees does The BRAS DDP have?
The BRAS DDP has 11-50 employees
What industry does The BRAS DDP belong to?
The BRAS DDP is in the industry of: Hospitals & Physicians Clinics, Business Services, Research & Development
What is The BRAS DDP competition?
The BRAS DDP top competitors include: Stand Up To Cancer Canada, Bras Family Foundation, Bladder Cancer Canada, London
What technology does The BRAS DDP use?
Some of the popular technologies that The BRAS DDP uses are: WooCommerce, WordPress.org, PHP, Google Font API
How do I contact The BRAS DDP?
The BRAS DDP contact info: Phone number: (416) 946-6560 Website: www.brasddp.com
What does The BRAS DDP do?

The BRAS Drug Development Program (BRAS DDP) is a leading cancer research initiative based at the Princess Margaret Cancer Centre in Toronto, recognized as the largest program in Canada and among the top five globally. Established to provide personalized cancer care, it focuses on conducting early phase clinical trials for patients with advanced ca... ncers, utilizing innovative drug studies to enhance treatment outcomes. With over $60.6 million in peer-reviewed funding since 2001, it is the only non-U.S. program funded by the U.S. National Institute of Health. The program aims to address the growing cancer crisis in Canada, where a significant portion of the population is affected by the disease.Read More

Is The BRAS DDP a public company?
The BRAS DDP is private company therefore does not currently have an official ticker symbol
See more information about The BRAS DDP

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.